Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GW Pharmaceuticals PLC (NASDAQ:GWPH)

85.04
Delayed Data
As of Aug 23
 +0.66 / +0.78%
Today’s Change
35.83
Today|||52-Week Range
120.94
+22.47%
Year-to-Date
Medtronic's HeartWare Takeover Complete for $1.1 Billion
6:31am / Zacks.com - Paid Partner Content
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug 19 / Zacks.com - Paid Partner Content
Phibro Animal Health: Currency & Competition Woes Persist
Aug 23 / Zacks.com - Paid Partner Content
Bruker's Q2 Results Disappoint, Product Launches Continue
Aug 18 / Zacks.com - Paid Partner Content
Illumina Rallies on Rumors of Takeover by Thermo Fisher
Aug 23 / Zacks.com - Paid Partner Content
3 Reasons GW Pharmaceuticals' Stock Could Rise
Aug 17 / MotleyFool.com - Paid Partner Content
Cardiovascular Systems (CSII) Catches Eye: Stock Up 5.6%
Aug 23 / Zacks.com - Paid Partner Content
Phibro (PAHC) Focuses on Growth Amid Pricing Pressure
Aug 17 / Zacks.com - Paid Partner Content
2 Big Back-Alley Brawls Break Out in Washington Over Policy
Aug 23 / MotleyFool.com - Paid Partner Content
Zimmer Biomet Acquires CD Diagnostics, Targets PJI Market
Aug 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close84.38
Today’s open85.00
Day’s range84.37 - 85.83
Volume196,058
Average volume (3 months)477,817
Market cap$2.1B
Dividend yield--
Data as of 08/23/2016

Growth & Valuation

Earnings growth (last year)-140.06%
Earnings growth (this year)-33.71%
Earnings growth (next 5 years)-48.37%
Revenue growth (last year)-11.81%
P/E ratio--
Price/Sales42.63
Price/Book4.94

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+1.25+1.17%
IRWDIronwood Pharmaceuti...+0.17+1.23%
PRTAProthena Corporation...-0.15-0.28%
PBYIPuma Biotechnology I...+1.97+3.60%
Data as of 08/23/2016

Financials

Next reporting dateNovember 15, 2016
EPS forecast (this quarter)-$1.40
Annual revenue (last year)$44.0M
Annual profit (last year)-$68.7M
Net profit margin-156.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer &
Executive Director
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts

Partner Offers

Search for Jobs